Background
Sulfur mustard (SM) or mustard gas (bis-2-(chloroethyl)) sulfide is a
blister-forming agent that was used as a chemical weapon [
1] in World War I (1917) for the first time and
against Iranian citizens during the Iraq Conflict (1980-1988), resulting in 100,000
chemically-injured victims[
2].
Currently, one-third of these victims suffer from secondary complications
[
1]. SM can cause damage to various
organs, especially the skin, respiratory tract, and eyes. In general, the various
complications of SM are caused by its alkylating effects on cellular components such
as DNA, RNA, and intramembranous proteins and lipids, resulting in metabolic and
genetic damage [
3‐
7].
In the skin, keratinocytes, particularly in the basal layer, are the main target
of SM alkylation [
4,
8]. The major chronic skin manifestations of SM are
erythema, xerosis, hypo- or hyper-pigmentation, contact dermatitis, and pruritus
[
9‐
12]. Cytokines have been shown to play a key role in acute and
chronic skin inflammation, including chronic contact dermatitis due to SM
[
13‐
18]. One of these important cytokines is transforming growth
factor-β (TGF-β), a 25 KD molecular weight (MW) homo-dimmer protein in its active
form [
19,
20]. TGF-β has 3 isoforms (TGF-β 1, 2, 3), Its
signaling is mediated by its transmembrane receptors, TR
1 and
TR
2, which have serine/threonine kinase activity
[
21]. The intracellular signaling
pathway of TGF-β is mediated by Smads molecules [
22,
23] that
eventually enter the nucleus, bind with transcription promoters/cofactors, and
regulate the transcription of DNA [
24‐
27]. TGF-β is
secreted from several cell types such as T cells, macrophages, platelets,
endothelial cells, keratinocytes, and fibroblasts o[
28,
29]; it is a
multi-functional cytokine with biological effects ranging from cell differentiation
and growth inhibition to extracellular matrix stimulation, immuno-suppression, and
immuno-modulation [
29,
30]. There have been data suggesting that the
anti-inflammatory effect of TGF-β on Th1 and Th2 production and differentiation in
macrophages and dendritic cells is a key issue in the skin manifestations of SM
[
21,
27,
31‐
38].
To evaluate the possible role of TGF-β and its receptors in chronic inflammatory
skin lesions caused by SM and symptoms like pruritus, we attempted to assess the
expression of TGF-β and its receptors in the skin lesions of chemical-injured
victims of SM in comparison with normal controls.
Methods
Sampling
The subjects of this study were 17 male SM chemically-injured patients between
the ages of 38 and 70 without an exposure history to toxic agents other than SM,
17 male chronic contact dermatitis patients between the ages of 20 and 68 without
history of exposure to SM, and 5 healthy male participants between the ages of 21
and 58. The means and standard deviations (mean ± SD) of age were 48.47 ± 9.3,
46.52 ± 14.6 and 44.00 ± 14.6 for MS chemically-injured patients, chronic contact
dermatitis patients and normal ones, respectively, and there were no significant
differences in ages among the three groups (p > 0.05). The chemically-injured
patients had documented histories of exposure to SM during the Iran-Iraq war
(1983-88), and the chronic contact dermatitis patients had sought ambulatory
medical treatment at a dermatology hospital. People with histories of addiction or
topical treatment during the 48 hours before biopsy were excluded from the study.
Informed consent was obtained from all the patients and normal men to be examined,
and all of them were aware of the probable consequences of a skin biopsy.
The severity of the pruritus was measured subjectively by a pruritus scale
(0-3). Score 0: no itching, Score 1: mild itching but no significant disturbance
of daily activities; Score 2: moderate itching causing disturbance of daily
activities; Score 3: severe itching causing disturbance in night sleep.
Biopsy specimens (3 mm
2
size and about 25 mg weight) were taken from
pruritic plaque skin lesions under topical anesthesia with 2% lidocaine and put
into trizol or 4% buffered paraformaldehyde. The
samples in trizol were transferred via -20°C rack to store at -80°C until RNA
extraction, while those in formalin were placed in the refrigerator for
fixation.
Total RNA was harvested in conformity with manufacturer's recommendations
using trizol reagent (Invitrogen, Carlsbad, CA). Briefly described, skin biopsy
specimens were homogenized in trizol by mean of an ultrasonic homogenator. After
adding 200 μl chloroform (Merck, Germany) and centrifuging at 12,000 rpm, RNA
containing homogenates in the aqueous phase were separated, and the same volume of
isopropranol was added. To avoid contamination with proteins, the lowest fraction
of the aqueous phase was not incorporated into the total RNA sample. Following
centrifugation, precipitated RNA was dissolved in ethanol at 75% and centrifuged
again at 1200 rpm. Isolated RNA was eluted in 20 μl RNAase-free water, and the
quantity and integrity of RNA were measured by Nano Drop (ND-1000 UV - Vis
spectrophotometer).
Primer design
The primer sets for TGF-β1, TGF-β2, TGF-β receptor 1, TGF-β receptor 2, and
β-actin (control gene) are shown in Table
1.
Table 1
Primer designs and sequences for TGF-β1 ,
TGF-β 2 , TGF-βR1 and
TGF-βR2
242 bp | 59 | 5'TCAAGCAGAGTACACACAGC3' | TGF-β1 Forward Primer |
| 59 | 5'GCACAACTCCGGTGACATC3' | TGF-β1 Reverse Primer |
220 bp | 57 | 5'TTGACGTCTCAGCAATGGAG3' | TGF-β2 Forward Primer |
| 57 | 5'TCAGTTACATCGAAGGAGAGC3' | TGF-β2 Reverse Primer |
190 bp | 56 | 5'TGCTGCAATCAGGACCATTG3' | TGF-βR1 Forward Primer |
| 56 | 5'TCCTCTTCATTTGGCACTCG3' | TGF-βR1 Reverse Primer |
210 bp | 57 | 5'TGCTCACCTCCACAGTGATC3' | TGF-βR2 Forward Primer |
| 57 | 5'TCTGGAGCCATGTATCTTGC3' | TGF-βR2 Reverse Primer |
190 bp | 59 | 5'TCATGAAGATCCTCACCGAG3' | β-actin Forward Primer |
| 59 | 5'TTGCCAATGGTGATGACCTG3' | β-actin Reverse Primer |
Table 2
Severity of pruritus according to the pruritus scale in
chemically-injured and chronic contact dermatitis patients
Mild | 0% | 17.6% |
Moderate | 0% | 29.4% |
Severe | 100% | 53.0% |
cDNA synthesis and Semi quantitative RT-PCR
Aliquots of 500 ng total RNA were
reverse-transcribed to create first-strand complementary DNA by superscript III
reverse-transcriptase (Invitrogen) according to the manufacturer's protocol. The
resulting 1 μl of cDNA was validated with PCR in a volume of 25 ml containing 2.5
μl buffer (10x Takara), 5pm deoxynucleoside triphosphate, 0.3 μL rTq polymerase
(Cinagene, Tehran, Iran) and 10 pm primer mix. PCR was carried out in the same
solution with heat held at 95°c for 3 min, denaturation at 95°c for 30 sec, and
annealing at 59°C, 57°C, 58°C, 56°C, 57°C, or 59°C for TGF-β1, TGF-β2, TGF-β
receptor 1, TGF-β receptor 2, and β-actin, respectively, for 30 sec, extension at
72°C for 1 min (33 cycle), terminal extension at 72°c for 5 min, and a terminal
hold at 4°C. PCR products were separated by 2% agarose gel electrophoresis, and
the quantity of the bands was visually detectable under UV light after dying with
ethidium bromide. All results were normalized with β-actin expression to
compensate for differences in cDNA amount. Image analysis (using Scion Image
software) was done to obtain quantitative data. (Scion Corporation, Frederick,
MD)
Immunohistochemistry
Details of the immunohistochemistry are already described elsewhere
[
39]. In brief, skin biopsy
specimens were placed in 4% buffered paraformaldehyde for fixation.
After immersion overnight in phosphate buffer containing 30% sucrose, 20 μm
thicktissue sections were cut on a cryostat and incubated with HO-1 antibody
(1:200 dilution in phosphate buffer) for 12 h at 4°C. The antibody used in this
study was a mouse monoclonal IgG1 antibody raised against
recombinant TGF-β1 of human origin (Santa Cruz
Biotechnology, Inc, USA) at a dilution of 1:200. After incubation with the primary
antibody, the sections were washed with PBS and incubated with biotinylated
anti-mouse secondary antibody (Santa Cruz
Biotechnology, Inc, USA). Antigen-antibody reaction sites were detectable
using an ABC complex (avidin-biotinylated peroxidase complex) system (Vector
Laboratory, Burlingame, CA, USA) with DAB as a substrate. For the negative
control, phosphate-buffered saline (PBS) was substituted for the primary
antibody.
Statistical analysis
Data were analyzed by one-way ANOVA followed by a Bonferroni's test for
multiple comparisons (using SPSS version 13). A level of P < 0.05 was
considered statistically significant. All results were expressed as means ±
SD.
Discussion
Our results show that loss of expression of TGF-β1, TGF-β2, TGF-β receptor 1,
and TGF-β receptor 2 genes in chemically injured patients is significantly more
severe than in chronic contact dermatitis patients when compared with normal
controls. Additionally, the frequency of severely pruritic cases is
significantlyhigher in chemically injured patients than in chronic contact
dermatitis patients.
Sulfur mustard and its effects on skin inflammation and the inflammatory
cytokines have previously been examined in several different studies. In one animal
study, the response of inflammatory cytokines was assessed in sulfur mustard-exposed
mouse skin. The results emphasized the distinct role of IL-6 as a proinflammatory
biomarker in sulfur mustard skin injury [
13,
14]. In another
study, alternations of gene expression of inflammatory cytokines were detected in
sulfur mustard exposed skin; the results showed significant increases in the
expression of inflammatory cytokines (IL-1B, GM-CSF, IL-6) following cutaneous
sulfur mustard exposure [
15].
It is well known that regulatory T lymphocytes produce TGF-β and that these
cells may also prepare IL-10, which, like TGF-β, has immunosuppressive effects
[
18]. In agreement with this fact, an
interesting study has shown that overexpression of IL-10 following exposure to
sulfur mustard can suppress the proinflammatory cytokines (IL-8 and IL-6) in human
epidermal keratinocytes and lead to delayed cell death [
40]. These findings are in agreement with our
research results showing that TGF-β, like IL-10, can also have a distinct role in
the modulation of skin inflammation of mustard gas. Loss of expression of TGF-βs and
their receptors in the skin lesions of chemical victims may lead to retention of
inflammation in the skin and chronic skin manifestations like pruritus because of
lack of TGF-β control.
An animal investigation clearly reports that remarkable inflammatory lesions are
detected in many organs of TGF-β1-negative mice [
35]. Moreover, severe immune pathology was detected in TGF-β
knockout mice [
30], supporting our
results.
The importance of the antiinflammatory role of TGF-β has been also emphasized in
studies of signaling pathway mediators like Smad 3. These reports testify to this
fact that TGF-β signaling via Smad 3 has an important role in modulation of
inflammation in atopic and contact dermatitis; TGF-βs and theirs signaling mediators
bridle the inflammation flares mediated by other cytokines, chemokines, and
inflammatory cells. In future studies, Smad molecules should be examined as possible
targets in the skin lesions of chemical victims.
In some other studies, it has been demonstrated that TGF-β has a important in
wound healing; thus we see delays in wound healing in TGFβ1-knockout mice
[
45]. This finding suggests that loss
of expression of the TGF-β family in skin lesions of mustard gas may explain the
chronic skin complaints of these patients.
Various studies have checked the expression of TGF-β family and their receptors
in normal skin and different regions; most of them agree that the expression of
TGFβ1, 2, 3 and TGF-β R1, TGF-β R2 (as mRNA or protein levels) is detectable in
human keratinocytes and layers of the skin. Our investigation also detected this
expression at the mRNA and protein levels, particularly in normal samples which
usually express TGF-βs and their receptors.
Matrix - Metallo proteinases (MMPs) also have a role in the inflammatory
processes of sulfur mustard [
50]; other
research has shown that TGF-β can inhibit MMPs [
29,
51]. Without the
inhibitory control of TGF-βs, these MMPs can be expected to continue their
inflammatory effects. It has also been suggested that a lack of TGF-β may play an
important role in both hyperproliferation and malignant conversion in the skin and
skin tumors [
52].
Paradoxically, a few studies have described proinflammatory mechanisms of TGF-β
in skin pathologic conditions and its effects on chemo attraction [
30,
53‐
55]. These studies
question the overall assumption that TGF-β primarily has anti-inflammatory and
immuno-modulatory effects. Future investigations should clearly focus on analyzing
TGF-β roles in immunopathological processes.
Finally, it is important to consider studies which have assessed some
therapeutic approaches to this type of poisoning. The use of anti-oxidants and
inhibitors of NF-Kappaβ has been shown to be beneficial for sulfur mustard treated
human keratinocytes [
56,
57].
Moreover, another study has suggested that the TGF-β/Smad pathway can be useful
in the treatment of atopic dermatitis [
44].
Some other investigations have focused on the induction of
TGF-β
1 and TGF-β
2 secretion by
retinoic acid (isotretinoin) [
58],
which can lead to inhibitory effects of TGF-β on both inflammation and proliferation
in the skin [
59,
60]. Calcipotriol (a vitamin D3 analogue) has been
described to increase the secretion and activation of TGF-β1 and TGF-β2 in murine
skin cells [
61]. In another study,
tacrolimus ointment (FK506) appeared to upregulate TGF-β release in keratinocytes as
a treatment goal in dermatitis; this again reinforces an anti-inflammatory role for
TGF-β in skin disorders [
62,
63].
These therapeutic studies may help us in future investigations targeting the
TGF-β family and its signaling pathway and designed to cure or diminish the chronic
skin manifestations of sulfur mustard damage, including chronic pruritus, which is
resistant to common remedies.
Conclusions
In summary, we clarified that most chemically injured patients did not express
TGF-β1, TGF-β2, TGF-β receptor 1, or TGF-β receptor 2. All of this group of patients
have severe pruritus as a chief complaint.
Nevertheless, detailed information about mustard gas effects on human skin,
particularly at the molecular level, is very limited, and this investigation with
such a small sample size cannot answer all the remaining questions. However, it can
serve as a trigger for new research examining the molecular pathology of SM skin
injury and thus developing new therapeutic approaches.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
IK carried out the molecular biology studies, alignment and drafted the
manuscript, participated in the clinical examination data. SA clinical examination
and taking biopsies. AAIF participated in the molecular biology analysis. ME
participated in the molecular biology analysis. SY carried out the immunoassays. MS
participated in the design of the study. YP participated in the design of the study.
MRN as corresponding author participated in all stages of study and participated in
its design and coordination and helped to draft the manuscript. All authors read and
approved the final manuscript.